Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.
The ecological study determined that per- and poly-fluoroalkyl substances (PFAS) from drinking water through examination of the associations between PFAS in drinking water measured in two waves ...
Anyone with unopened, unused cancer medication can donate the drugs at McLaren Central Michigan, and MyMichigan Medical Centers in Mt. Pleasant, Midland and Clare Monday through Friday, according to ...